Quest Laboratories
QUESTLAB · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
1.8%
1w
9.0%
1m
22.5%
3m
15.4%
all
10.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 109 1.8%
84
112
Company Overview

Sales
91.4 Cr
Growth: 65.7%
Profit after Tax
15.7 Cr
Growth: 19.4%
Micro Cap
179 Cr
P/E: 11.4x
Industry P/E: 33.1x
Fundamentals

Sales (Cr) ₹ 91.4
Growth 65.7%
EBITDA 19.5%
P/S 2.0x
Dividend 0.0%
P/E 11.4x
Book Value ₹ 10
PEG Ratio 0.2x
ROE 95.6%
P/B N/A
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is primarily engaged in the manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The company also produces variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).
Belongs to (1 Indices)